Gregory Lucier, Director at NuVasive, holds 87.73K shares in DENTSPLY SIRONA (Ticker: XRAY), holds 36.91K shares in Catalent (Ticker: CTLT), holds 75.77K shares in Maravai Lifesciences Holdings (Ticker: MRVI). Most recently, Gregory Lucier Bought ― shares of DENTSPLY SIRONA on Nov 18, 2024 for an estimated value of 110.07K.
Gregory Lucier latest transaction was an Informative Buy of $110.07K.
What was Gregory Lucier's most profitable transaction?
Gregory Lucier’s most profitable transaction was an Informative Buy of CTLT stock on February 14, 2020. The return on the trade was 107.20%.
What is Gregory Lucier's role in NuVasive?
Gregory Lucier's role in NuVasive is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.